Obermayer, A.; Tripolt, N.J.; Aziz, F.; Högenauer, C.; Aberer, F.; Schreiber, F.; Eherer, A.; Sourij, C.; Stadlbauer, V.; Svehlikova, E.;
et al. EndoBarrier™ Implantation Rapidly Improves Insulin Sensitivity in Obese Individuals with Type 2 Diabetes Mellitus. Biomolecules 2021, 11, 574.
https://doi.org/10.3390/biom11040574
AMA Style
Obermayer A, Tripolt NJ, Aziz F, Högenauer C, Aberer F, Schreiber F, Eherer A, Sourij C, Stadlbauer V, Svehlikova E,
et al. EndoBarrier™ Implantation Rapidly Improves Insulin Sensitivity in Obese Individuals with Type 2 Diabetes Mellitus. Biomolecules. 2021; 11(4):574.
https://doi.org/10.3390/biom11040574
Chicago/Turabian Style
Obermayer, Anna, Norbert J. Tripolt, Faisal Aziz, Christoph Högenauer, Felix Aberer, Florian Schreiber, Andreas Eherer, Caren Sourij, Vanessa Stadlbauer, Eva Svehlikova,
and et al. 2021. "EndoBarrier™ Implantation Rapidly Improves Insulin Sensitivity in Obese Individuals with Type 2 Diabetes Mellitus" Biomolecules 11, no. 4: 574.
https://doi.org/10.3390/biom11040574
APA Style
Obermayer, A., Tripolt, N. J., Aziz, F., Högenauer, C., Aberer, F., Schreiber, F., Eherer, A., Sourij, C., Stadlbauer, V., Svehlikova, E., Brunner, M., Goswami, N., Kojzar, H., Pferschy, P. N., Pieber, T. R., & Sourij, H.
(2021). EndoBarrier™ Implantation Rapidly Improves Insulin Sensitivity in Obese Individuals with Type 2 Diabetes Mellitus. Biomolecules, 11(4), 574.
https://doi.org/10.3390/biom11040574
